Gout
News
New gout drug under investigation has dual benefit
Key clinical point: The investigational uricosuric drug arhalofenate significantly reduced the incidence of flares in gout patients and also...
News
ACR’s 2016-2020 research agenda built through consensus
News
Prednisolone, indomethacin similarly effective for acute gout
Key clinical point: Oral prednisolone is as effective as indomethacin for relieving pain in acute gout and should be considered a first-line...
News
FDA approves lesinurad for uric acid lowering in gout
Conference Coverage
ACR: Don’t be fooled by contaminated synovial fluid
Hold off on surgery in patients with presumed septic arthritis if they’re not otherwise too sick and their cultures don’t grow out a pathogenic...
Conference Coverage
Gout hospitalizations, costs surpass those for rheumatoid arthritis
Key clinical point: Hospitalizations and costs for gout in the United States have surpassed those for rheumatoid arthritis, reflecting stark...
Conference Coverage
ACR: Study confirms potential genetic basis for poor response to allopurinol in gout
Key clinical point: Screening could identify gout patients who require a dose adjustment of allopurinol. Major finding: Presence of the rs2231142...
News
FDA advisory committee recommends approval of gout drug lesinurad, with caveats
Conference Coverage
Gout treatment lore doesn’t hold up to evidence
It’s okay to start urate lowering therapy during a gout attack, according to Dr. Brian Mandell, a rheumatology professor at the Cleveland Clinic...